IONSIonis Pharmaceuticals Inc
Slide 1 of 3
Company Overview
Name
Ionis Pharmaceuticals Inc
52W High
$86.74
52W Low
$42.63
Market Cap
$7.5B
Dividend Yield
0%
Price/earnings
-0.69
P/E
-0.69
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$267.9M
Operating Revenue
$267.9M
Total Gross Profit
$265.2M
Total Operating Income
$-102.3M
Net Income
$-114.6M
EV to EBITDA
$0.00
EV to Revenue
$8.07
Price to Book value
$17.11
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$150.4M
Research & Development Expense
$217.1M
Total Operating Expenses
$-367.5M
Interest Expense
$-22.1M
Interest & Investment Income
$10M
Other Income / (Expense), net
$1M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Ionis Pharmaceuticals Inc
52W High
$86.74
52W Low
$42.63
Market Cap
$7.5B
Dividend Yield
0%
Price/earnings
-0.69
P/E
-0.69
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$267.9M
Operating Revenue
$267.9M
Total Gross Profit
$265.2M
Total Operating Income
$-102.3M
Net Income
$-114.6M
EV to EBITDA
$0.00
EV to Revenue
$8.07
Price to Book value
$17.11
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$150.4M
Research & Development Expense
$217.1M
Total Operating Expenses
$-367.5M
Interest Expense
$-22.1M
Interest & Investment Income
$10M
Other Income / (Expense), net
$1M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Brett P. Monia
Location
California, USA
Exchange
Nasdaq
Website
https://ionispharma.com
Summary
Ionis Pharmaceuticals, Inc.
Company Info
CEO
Brett P. Monia
Location
California, USA
Exchange
Nasdaq
Website
https://ionispharma.com
Summary
Ionis Pharmaceuticals, Inc.
AI Insights
Be the first to know. We'll notify you when AI insights for IONS go live.
Community Research
Research from investors like you
Be the first to share your analysis on IONS
Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.
Topics: Company overview • Products • Competitors • Strengths & Risks
Symbol's posts
@democratiCrayn 2 weeks ago
Ionis Pharmaceuticals (IONS) down 40% YTD, but analysts still maintain $83 average price target
Ionis Pharmaceuticals (IONS) down 40% YTD, but analysts still maintain $83 average price target
www.fool.com
| Investors Dumped Ionis Pharmaceuticals Stock -- But Wall Street Hasn't Budged From Its Bullish Outlook | The Motley Fool
No more topics to show